Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (Dapan-Dia) evaluating dapansutrile for type 2 diabetes and related complications is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapansutrile (dapansutrile)

Snippet

Sponsor: Marc Donath | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: RECRUITING